comprehensive -WSS

comprehensive

author：knowledge 2025-09-30 20:46:51 - browse：1541

Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT — Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Prime Medicine, Myeloid Therapeutics clash over genome

focus

WSS

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Christmas in the PICU brings some surprising joy

SNAP should offer more nutrition education

Editas, Vertex strike deal on CRISPR

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Violet CEO on training clinicians to promote more inclusive care

hotspot

comprehensive

focus

In Memoriam: Notable people who died in 2023

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Medical records are filled with copy

Researchers test human milk's ability to repair gut microbiome

The high cost of giving birth even with insurance

Bird flu in dairy cattle: New measures to control spread to humans

Medical leaders decry Supreme Court decision on affirmative action

Covid silver lining: Unprecedented look at human immune system

How one medical school became remarkably diverse

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Wikipedia

Carvykti CAR

Mass General Brigham physicians react to latest merger step

Can sheer will power keep patients alive in their dying hours?

CRISPR gene editing developments we’re watching in 2024

Gut bacteria may contribute to kidney autoimmunity, study finds

Scientists uncover potential path to treating deadly childhood tumor

hotspot

focus

leisure time

leisure time